Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
270 results found
2017 ∙ Falkenhorst, G. Remschmidt, C. Harder, T. Hummers-Pradier, E. Wichmann, O. Bogdan, C.
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPV23) against pneumococcal disease in the elderly: systematic review and meta-analysis
Adults Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Low
2017 ∙ Porchia, B. R. Bonanni, P. Bechini, A. Bonaccorsi, G. Boccalini, S.
Evaluating the costs and benefits of pneumococcal vaccination in adults
Adults Older adults Pneumococcal disease Economic aspects
Rating:
Not applicable
2017 ∙ Cohen, R. Cohen, J. F. Chalumeau, M. Levy, C.
Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries
Newborn Children Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2017 ∙ Tsaban, G. Ben-Shimol, S.
Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature
Children Adolescents Adults Older adults Pneumococcal disease Coverage
Rating:
Not applicable
2017 ∙ Shiri, T. Datta, S. Madan, J. Tsertsvadze, A. Royle, P. Keeling, M. J. McCarthy, N. D. Petrou, S.
Indirect effects of childhood pneumococcal conjugate vaccination on invasive pneumococcal disease: a systematic review and meta-analysis
All age groups Pneumococcal disease Efficacy/effectiveness Coverage
Rating:
Critically low
2017 ∙ Walters, J. A. Tang, J. N. Poole, P. Wood-Baker, R.
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
All age groups Pneumococcal disease Efficacy/effectiveness Administration Economic aspects Safety
Rating:
High
2017 ∙ Duan, K. Guo, J. Lei, P.
Safety and Immunogenicity of Pneumococcal Conjugate Vaccine in Preterm Infants: A Meta-Analysis
Newborn Children Pneumococcal disease Efficacy/effectiveness Safety
Rating:
Critically low
2017 ∙ Katoh, Shungo Suzuki, Motoi Ariyoshi, Koya Morimoto, Konosuke
Serotype replacement in adult pneumococcal pneumonia after the introduction of seven-valent pneumococcal conjugate vaccines for children in Japan: a systematic literature review and pooled data analysis
Western Pacific Japan Adults Pneumococcal disease Administration Efficacy/effectiveness
Rating:
Critically low
2017 ∙ Cafiero-Fonseca, E. T. Stawasz, A. Johnson, S. T. Sato, R. Bloom, D. E.
The full benefits of adult pneumococcal vaccination: a systematic review
Adults Older adults Pneumococcal disease Economic aspects Efficacy/effectiveness
Rating:
Not applicable
2017 ∙ Alicino, C. Paganino, C. Orsi, A. Astengo, M. Trucchi, C. Icardi, G. Ansaldi, F.
The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis
Newborn Children Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
Loading...